Case number 1:23-cv-00152
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals U.S.A., Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 27, 2024 | 111 | ORDER: IT IS HEREBY ORDERED that Defendants' Motion for Judgment on the Pleadings (C.A. No. 23-152, D.I. 98; C.A. No. 23-153, D.I. 90) is DENIED. Within 21 days, the parties shall jointly prepare and file a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent". (*See Order for details). Signed by Judge Jennifer L. Hall on 6/27/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 06/27/2024) (3) |
| Feb 2, 2024 | 110 | ORAL ORDER: These cases having been reassigned to me on January 12, 2024, and it appearing that there are pending Motions (No. 23-152, D.I. 74; No. 23-153, D.I. 67) that relate to pleadings that are no longer the operative pleadings, and it further appearing that the parties agreed on May 8, 2023, that the pending motions should be withdrawn (No. 23-152, D.I. 93; No. 23-153, D.I. 85), IT IS HEREBY ORDERED that the Motions are DISMISSED. Ordered by Judge Jennifer L. Hall on 2/2/2024. Associated Cases: 1:23-cv-00152-JLH, 1:23-cv-00153-JLH(ceg) (Entered: 02/02/2024) (0) |
| Aug 23, 2023 | 109 | REQUEST for Oral Argument by Teva Pharmaceuticals U.S.A., Inc., Apotex Corp. re (98 in 1:23-cv-00152-CFC) MOTION for Judgment on the Pleadings . (Hoeschen, Nathan) (Entered: 08/23/2023) (2) |
| Aug 16, 2023 | 108 | REPLY BRIEF re 98 MOTION for Judgment on the Pleadings filed by Teva Pharmaceuticals U.S.A., Inc.. (Hoeschen, Nathan) (Entered: 08/16/2023) (18) |
| Aug 7, 2023 | 107 | NOTICE of Change of Address of Sterne, Kessler, Goldstein & Fox P.L.L.C. by Teva Pharmaceuticals U.S.A., Inc. (DiBenedetto, Emily) (Entered: 08/07/2023) (2) |
| Aug 1, 2023 | 105 | Joint STIPULATION TO EXTEND TIME for defendants Apotex Inc., Apotex Corp., and Teva Pharmaceuticals USA, Inc. to file a reply brief in support of defendants' Motion for Judgment on the Pleadings to August 16, 2023 - filed by Teva Pharmaceuticals U.S.A., Inc.. (DiBenedetto, Emily) (Entered: 08/01/2023) (2) |
| Aug 1, 2023 | 106 | SO ORDERED, re (97 in 1:23-cv-00153-CFC, 105 in 1:23-cv-00152-CFC) Joint STIPULATION TO EXTEND TIME for defendants Apotex Inc., Apotex Corp., and Teva Pharmaceuticals USA, Inc. to file a reply brief in support of defendants' Motion for Judgment on the Pleadings to August 16, 2023, filed by Teva Pharmaceuticals U.S.A., Inc. Reset Briefing Schedule: re (98 in 1:23-cv-00152-CFC, 90 in 1:23-cv-00153-CFC) MOTION for Judgment on the Pleadings. Reply Brief due 8/16/2023. Signed by Judge Colm F. Connolly on 8/1/2023. Associated Cases: 1:23-cv-00152-CFC, 1:23-cv-00153-CFC(kmd) (Entered: 08/01/2023) (2) |
| Jul 27, 2023 | 104 | DEFICIENCY NOTICE by the Court issued to Vanda Pharmaceuticals Inc. re (103 in 1:23-cv-00152-CFC, 95 in 1:23-cv-00153-CFC) Answering Brief in Opposition. Pursuant to the Court's Standing Order Regarding Briefing in All Cases, dated November 10, 2022, "[t]he covers of briefs filed in connection with all motions except for motions in limine included in a pretrial order shall be as follows: i. Opening Brief - Blue; ii. Answering Brief - Red; iii. Reply Brief - Gray." Courtesy copies of D.I. 103 in 1:23-cv-00152-CFC, 95 in 1:23-cv-00153-CFC are not in compliance with the Court's standing order. Please resubmit courtesy copies of your brief with the corrected covers. Associated Cases: 1:23-cv-00152-CFC, 1:23-cv-00153-CFC (kmd) (Entered: 07/27/2023) (2) |
| Jul 26, 2023 | 103 | ANSWERING BRIEF in Opposition re 98 MOTION for Judgment on the Pleadings filed by Vanda Pharmaceuticals Inc..Reply Brief due date per Local Rules is 8/2/2023. (Attachments: # 1 Certificate of Compliance)(Joyce, Alexandra) (Entered: 07/26/2023) (0) |
| Jul 10, 2023 | 101 | STIPULATION TO EXTEND TIME the Deadline for Plaintiff Vanda Pharmaceuticals Inc. to Respond to Defendants' Motion for Judgment on the Pleadings to July 26, 2023 - filed by Vanda Pharmaceuticals Inc.. (Joyce, Alexandra) (Entered: 07/10/2023) (3) |
| Jul 10, 2023 | 102 | SO ORDERED, re (101 in 1:23-cv-00152-CFC, 93 in 1:23-cv-00153-CFC) STIPULATION TO EXTEND TIME the Deadline for Plaintiff Vanda Pharmaceuticals Inc. to Respond to Defendants' Motion for Judgment on the Pleadings to July 26, 2023, filed by Vanda Pharmaceuticals Inc. Reset Briefing Schedule: re (98 in 1:23-cv-00152-CFC) (90 in 1:23-cv-00153-CFC) MOTION for Judgment on the Pleadings. Answering Brief due 7/26/2023. Signed by Judge Colm F. Connolly on 7/10/2023. Associated Cases: 1:23-cv-00152-CFC, 1:23-cv-00153-CFC(kmd) (Entered: 07/10/2023) (3) |
| Jun 28, 2023 | 98 | MOTION for Judgment on the Pleadings - filed by Teva Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Text of Proposed Order)(Hoeschen, Nathan) (Entered: 06/28/2023) (Main Document) (2) |
| Jun 28, 2023 | 99 | OPENING BRIEF in Support re 98 MOTION for Judgment on the Pleadings filed by Teva Pharmaceuticals U.S.A., Inc..Answering Brief/Response due date per Local Rules is 7/12/2023. (Hoeschen, Nathan) (Entered: 06/28/2023) (27) |
| Jun 28, 2023 | 100 | DECLARATION re 99 Opening Brief in Support [Declaration of Kaan Ekiner in Support of Defendants' Motion for Judgment on the Pleadings] by Teva Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Hoeschen, Nathan) (Entered: 06/28/2023) (Main Document) (2) |
| Jun 28, 2023 | 100 | DECLARATION re 99 Opening Brief in Support [Declaration of Kaan Ekiner in Support of Defendants' Motion for Judgment on the Pleadings] by Teva Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Hoeschen, Nathan) (Entered: 06/28/2023) (Exhibit 1) (3) |
| Jun 28, 2023 | 100 | DECLARATION re 99 Opening Brief in Support [Declaration of Kaan Ekiner in Support of Defendants' Motion for Judgment on the Pleadings] by Teva Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Hoeschen, Nathan) (Entered: 06/28/2023) (Exhibit 2) (5) |
| Jun 28, 2023 | 98 | MOTION for Judgment on the Pleadings - filed by Teva Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Text of Proposed Order)(Hoeschen, Nathan) (Entered: 06/28/2023) (Text of Proposed Order) (2) |
| Jun 9, 2023 | 97 | ANSWER to 96 Answer to Amended Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Silver, Daniel) (Entered: 06/09/2023) (15) |
| May 26, 2023 | 96 | ANSWER to Amended Complaint, re: 94 Amended Complaint , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Teva Pharmaceuticals U.S.A., Inc..(Keller, Karen) (Entered: 05/26/2023) (30) |
| May 16, 2023 | 95 | NOTICE of Withdrawal of Motion for Judgment on the Pleadings (C.A. No. 23-152, D.I. 85; C.A. No. 23-153, D.I. 77) by Teva Pharmaceuticals U.S.A., Inc. (Hoeschen, Nathan) (Entered: 05/16/2023) (2) |
| May 12, 2023 | 94 | Amended Complaint* (1) |
